Otros idiomas Zai Lab Limited

Acciones

ZLAB

US98887Q1040

Farmacéuticos

Mercado cerrado - Nasdaq 21:00:00 09/03/2026 Variación 5 días Varia. 1 de enero.
19,12 USD -2,15 % Gráfico intradía de Zai Lab Limited +3,80 % +8,39 %

Otros idiomas

04/03 Asian Equities Traded in the US as American Depositary Receipts Rise Modestly in Wednesday Trading
02/03 Asian Equities Traded in the US as American Depositary Receipts Drop Sharply in Monday Trading
27/02 Zai Lab's Q4 Loss Narrows as Revenue Jumps 17%
26/02 Zai Lab Limited Reports Earnings Results for the Fourth Quarter Ended December 31, 2025
26/02 Zai Lab Q4 Loss Narrows, Revenue Rises
26/02 Earnings Flash (ZLAB) Zai Lab Limited Reports Q4 Revenue $127.6M, vs. FactSet Est of $122.2M
26/02 Earnings Flash (ZLAB) Zai Lab Limited Reports Q4 Loss of $0.46 per ADS
26/02 Zai Lab : ZLAB 4Q25 Corporate Presentation EN vf
26/02 Zai Lab Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates
13/02 Asian Equities Traded in the US as American Depositary Receipts Advance in Friday Trading
10/02 Zai Lab to Announce Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates on February 26, 2026
05/02 $207B Market Shift: The Race for Fast Track Approval in Oncology
03/02 Asian Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading
15/01 Asian Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
14/01 Asian Equities Traded in the US as American Depositary Receipts Slightly Higher in Wednesday Trading
13/01 Asian Equities Traded in the US as American Depositary Receipts Slightly Higher in Tuesday Trading
13/01 Zai Lab : JPM 2026 Presentation vFinal
13/01 Zai Lab Highlights Strategic Priorities and Global Pipeline Progress at 44th Annual J.P. Morgan Healthcare Conference
12/01 Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Monday Trading
07/01 Asian Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
06/01 Zai Lab Announces National Medical Products Administration Approval of AUGTYRO?? (repotrectinib) for Patients with NTRK-Positive Solid Tumors
06/01 Zai Lab Announces National Medical Products Administration (NMPA) Approval of AUGTYRO™ (repotrectinib) for Patients with NTRK-Positive Solid Tumors
05/01 Asian Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
05/01 Zai Lab to Present at 44th Annual J.P. Morgan Healthcare Conference
02/01 Asian Equities Traded in the US as American Depositary Receipts Climb in Friday Trading
No hay resultados para esta búsqueda
SPRING SALE -40%: ¡Descubre las mejores inversiones del futuro con las herramientas para suscriptores!
d
:
:
APROVECHAR LA PROMOCIÓN